Maven Securities LTD Leap Therapeutics, Inc. Transaction History

Maven Securities LTD

  • $774 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$2.08 - $3.65 $936,000 - $1.64 Million
-450,000 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$1.35 - $4.01 $607,500 - $1.8 Million
450,000 New
450,000 $1.81 Million
Q3 2020

Nov 13, 2020
SELL
$1.68 - $2.17 $972,498 - $1.26 Million
-578,868 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$1.39 - $2.84 $804,626 - $1.64 Million
578,868 New
578,868 $1.21 Million

Others Institutions Holding LPTX

# of Institutions
1
Shares Held
265K
Call Options Held
0
Put Options Held
0
View Full List

About LEAP THERAPEUTICS, INC.

LPTX Quotes by TradingView
  • Ticker LPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,021,400
  • Market Cap $275M
  • Description
  • Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...
More about LPTX
Track This Portfolio

Track Maven Securities LTD Portfolio

Follow Maven Securities LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maven Securities LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email